Advertisement

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Portugal and Spain or involving organisations from these countries.

Total search results: 203 | Ordered by Date (descending)
1 2 3  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Mestrelab Research–SpectralWorks: analytical instrument software, 201708– collab mutual reseller agreem for all respective NMR/MS s/w products 2017-08-15
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
GigaGen–Grifols: investment, acquisition of 44% stake in GigaGen Inc for $35m in cash by Grifols 2017-07-05
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Oryzon Genomics–JMP Securities: investor conference, 201706 supply service Oryzon at JMP Securities 2017 Life Sciences Conference NY 2017-06-20
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Oryzon Genomics–Leucadia: investor conference, 201706 supply service Oryzon presents at Jefferies Healthcare Conference in New York 2017-06-09
Oryzon Genomics–Trout Group: public relations, 201705 service existent investor relations by Trout Group 2017-05-31
AptaTargets–Inveready: investment, 201705 financing round totalling €2.7m from Caixa Capital Risc + Inveready 2017-05-17
AptaTargets–la Caixa: investment, 201705 financing round totalling €2.7m from Caixa Capital Risc + Inveready 2017-05-17
AptaTargets–SEVERAL: investment, 201705 financing round €2.7m from Caixa Capital Risc + Inveready 2017-05-17
Specialised Therapeutics Australia–PharmaMar: lurbinectedin, 201705– license to market lurbinectedin in AU + NZ + 12 Asian countries for STA 2017-05-17
Genetrix (ES)–SEVERAL: investment, 201705– capital increase up to €10m w rights offering + private placement Sygnis AG 2017-05-08
Innova Biosciences–Genetrix (ES): investment, 201705–201707 acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG 2017-05-08
Celyad–Deutsche Bank: investor conference, 201705 supply service Celyad presents at Deutsche Bank Annual Health Care Conference 2017-05-04
Vivet Therapeutics–Columbus Venture Partners: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor CVP 2017-05-04
Vivet Therapeutics–Huntsworth: public relations, 201705 service existent by Citigate Dewe Rogerson 2017-05-04
Vivet Therapeutics–Kurma: investment, 201705 financing round Series A totalling €37.5m incl co-investor Kurma Partners 2017-05-04
Vivet Therapeutics–Novartis: investment, 201705 financing round Series A totalling €37.5m incl co-lead investor Novartis Venture Fund 2017-05-04
Vivet Therapeutics–Odlander Fredrikson: investment, 201705 financing round Series A totalling €37.5m incl co-investor HealthCap 2017-05-04
Vivet Therapeutics–Roche: investment, 201705 financing round Series A totalling €37.5m incl co-investor Roche Venture Fund 2017-05-04
Vivet Therapeutics–SEVERAL: investment, 201705 financing round Series A €37.5m led by Novartis Venture Fund + Columbus Venture Partners 2017-05-04
Vivet Therapeutics–Ysios Capital: investment, 201705 financing round Series A totalling €37.5m incl co-investor Ysios Capital 2017-05-04
EMBL–Enamine: chemical compound library, 201704– collab library synthesis + medical chemistry + biological services for cancer drug research 2017-04-25
Oryzon Genomics–SEVERAL: investment, 201703 private placement €18.2m w 5.7m news common shares at €3.2/share 2017-03-31
Versantis–SEVERAL: investment, 201703 financing round Series A CHF4.4m led by Redalpine Venture Partners 2017-03-29
BioClin Therapeutics–Life Sciences Partners: investment, 201703 financing round Series B totalling $30m incl existing investor LSP 2017-03-22
BioClin Therapeutics–Odlander Fredrikson: investment, 201703 financing round Series B totalling $30m incl existing investor HealthCap 2017-03-22
BioClin Therapeutics–SEVERAL: investment, 201703 financing round Series B $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Sofinnova: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
BioClin Therapeutics–Tekla Capital: investment, 201703 financing round Series B totalling $30m incl existing investor Tekla Capital Management 2017-03-22
BioClin Therapeutics–Ysios Capital: investment, 201703 financing round Series B totalling $30m led by new investors Sofinnova Ventures + Ysios Capital 2017-03-22
Imegen (ES)–SEVERAL: investment, 201703 acquisition €10m of majority share in Imegen by Q-Growth Fund + Biolty 2017-03-16
Prexton Therapeutics–Forbion: investment, 201702 financing round Series B totalling €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–Merck (DE): investment, 201702 financing round Series B totalling €29m incl returning co-investor Merck Ventures 2017-02-07
Prexton Therapeutics–Seroba: investment, 201702 financing round Series B totalling €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–SEVERAL: investment, 201702 financing round Series B €29m co-led by new investors Forbion + Seroba 2017-02-07
Prexton Therapeutics–Sunstone Capital: investment, 201702 financing round Series B totalling €29m incl returning co-investor Sunstone Capital 2017-02-07
Prexton Therapeutics–Ysios Capital: investment, 201702 financing round Series B totalling €29m incl returning co-investor Ysios Capital 2017-02-07
Villapharma Research–Eurofins: investment, 201612– acquisition of Villapharma by Eurofins ANNOUNCED 2016-12-29
C.B.S. Scientific–Genetrix (ES): investment, 201612 acquisition $900k of C.B.S. Scientific Company for $540k cash + $360k in shares by Sygnis AG 2016-12-21
Hologic–Grifols: investment, 201612 agreem for Grifols to acquire Hologic’s interest in joint NAT donor screening business for $1.85b 2016-12-14
EURE-CART project–EU (govt): grant, 201612c– Horizon 2020 grant €5.9m 4y for clinical research on CART T-cell immunotherapy 2016-12-12
MolMed–EU (govt): grant, 201612c– Horizon 2020 grant €2m for MolMed for 4y as coordinator of EURE-CART project 2016-12-12
Biopremier (PT)–SGS: investment, 201612 acquisition of 70% stake by SGS 2016-12-09
Genetrix (ES)–GBC: investor conference, 201612 supply service Sygnis AG presents at MKK Münchner Kapitalmarkt Konferenz 2016 2016-12-07
OxThera–SEVERAL: investment, 201611 financing round €32m co-led by Life Sciences Partners + Ysios Capital + Sunstone Capital + Flerie Invest 2016-11-29
Neovacs–Infarco: biologics contract manufacturing, 201611– supply of IFNalpha by 3P Biopharmaceuticals to Neovacs 2016-11-23
Genetrix (ES)–Deutsche Börse: investor conference, 201611 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2016 2016-11-21
CorWave–SEVERAL: investment, 2013 financing round Series A 2016-11-04
CorWave–SEVERAL: investment, 201611 financing round Series B €15.5m led by new investor Novo Seeds 2016-11-04
Iproteos–SEVERAL: investment, 201610 financing round €1.5m led by Caixa Capital Risc + co-investors Kinled Holding + Ascil Biopharm 2016-10-25
Aura Biosciences–Ysios Capital: investment, 201610 existent investment of Ysios BioFund II Innverite FCR 2016-10-18
Megalab (ES)–Eurofins: investment, 201609 acquisition €40m of Megalab SA by Eurofins 2016-09-30
Oryzon Genomics–SEVERAL: credit, 201610 long-term loans €5.3m from Spanish commerical banks at current interest rates 2016-09-26
Oryzon Genomics–Informa: partnering conference, 201611 supply service Oryzon Presents at BioPharm America 2016 in Boston 2016-09-13
Oryzon Genomics–Rodman & Renshaw: investor conference, 201609 supply service Oryzon presents at Rodman & Renshaw Global Investment Conference in NY 2016-09-11
Oncovision–Bruker Corp: investment, 201609 acquisition €na of preclinical imaging business of Oncovision by Bruker 2016-09-07
DiViNe project–Affilogic: vaccine purification technology, 201609 collab Affilogic is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–Aquaporin: vaccine purification technology, 201609 collab Aquaporin is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–EU (govt): grant, 201609c– Horizon 2020 grant 5y to advance vaccine purification led by iBET 2016-09-01
DiViNe project–GSK: vaccine purification technology, 201609 collab GSK Italy is partner in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–iBET (PT): vaccine purification technology, 201609 collab GenIbet + iBET are partners in Horizon 2020 project led by iBET 2016-09-01
DiViNe project–Merck (DE): vaccine purification technology, 201609– collab Merck is partner in Horizon 2020 project led by iBET 2016-09-01
Thomson Reuters–Onex Corp: investment, 201607–201610 acquisition $3.55b in cash of Thomson Reuters IP + Science business by Onex + Baring PE Asia 2016-07-11
Nicox–GHO Capital: investment, 201607– acquisition €26m with €9m cash + €12m shares+loan notes + €5m milestones of Nicox commercial operations by GHO 2016-07-05
MetaSUB project–Qiagen: genomic sample preparation, 201606– collab project using Qiagen sample tech + library prepration workflows 2016-06-21
Expedeon–Genetrix (ES): investment, 201605–201608 acquisition of Expedeon Holdings Ltd by Sygnis AG for €1.7m cash + na shares 2016-05-09
Genetrix (ES)–SEVERAL: investment, 201605–201607 capital increase Sygnis AG €5.3m w 3m rights offering + 1.8m shares private placement €1.1/share 2016-05-09
Oryzon Genomics–SEVERAL: credit, 201605 long-term loans €10.5m from Spanish commerical banks at current interest rates 2016-05-04
Peptomyc–SEVERAL: investment, 201604 seed financing round €1m led by HealthEquity 2016-04-27
STAT-Diagnostica–Boehringer: investment, 201604 financing round Series C totalling €25m incl returning co-investor BIVF 2016-04-11
STAT-Diagnostica–Gilde Investment: investment, 201604 financing round Series C totalling €25m incl led + new investor Gilde Healthcare 2016-04-11
STAT-Diagnostica–SEVERAL: investment, 201604 financing round Series C €25m led by new investor Gilde Healthcare 2016-04-11
Interstate Blood Bank–Grifols: investment, 201604 acquisition of 49% share for $100m plus $10m option to acquire remaining shares for $100m 2016-04-01
Progenika–Grifols: investment, 2016Q1 acquisition €25m of additional 32.9% bringing total Grifols shareholding to 89.1% 2016-03-31
Almirall–Grünenthal: investment, 201603– acquisition 100% of Almirall de Mexico SA de CV by Grünenthal ANNNOUNCED 2016-03-15
IDP Pharma–SEVERAL: investment, 201602 2nd financing round €1.4m 2016-02-01
GoodGut (ES)–SEVERAL: credit, 201601 loans €300k each €150k from La Caixa VC program + AGAUR/IFEM program 2016-01-27
GoodGut (ES)–SEVERAL: investment, 201601 2nd financing round €315k from Girona BAGI business angels + other private investors 2016-01-27
Aelix Therapeutics–JnJ: investment, 201601 financing round Series A totalling €11.5m incl co-investor JJDC 2016-01-11
Aelix Therapeutics–la Caixa: investment, 201601 financing round Series A totalling €11.5m incl co-investor Caixa Capital Risc 2016-01-11
Aelix Therapeutics–SEVERAL: investment, 201601 financing round Series A €11.5m led by Ysios Capital + incl JJDC + Caixa Capital Risc 2016-01-11
Aelix Therapeutics–Ysios Capital: investment, 201601 financing round Series A totalling €11.5m incl lead investor Ysios Capital 2016-01-11
Oryzon Genomics–SEVERAL: investment, 201512 listing on Madrid Stock Exchange at €3.39/share 2015-12-14
Genetrix (ES)–SEVERAL: investment, 201512 rights offering + private placement of Sygnis AG €5.6m with 2.963m new shares €1.9/share 2015-12-10
Lucigen–Genetrix (ES): genomic reagents, 201512– distribution of Sygnis TruePrime + SunScript RT products for clinical oncology research in US 2015-12-03
Mayflower Bioscience–Genetrix (ES): genomic reagents, 201512– distribution of Sygnis TruePrime + SunScript RT products in US 2015-12-02
Poli Group–Almirall: investment, 201511– acquisition 100% of Poli Group Holding by Almirall ANNOUNCED 2015-11-30
Genetrix (ES)–Deutsche Börse: investor conference, 201511 supply service Sygnis AG presents at Deutsches Eigenkapitalforum 2015 2015-11-23
Zeltia–PharmaMar: investment, 201511 reverse merger with new company trading as PharmaMar at MSE 2015-11-02
BioLamina–Cevec: rec protein production technology, 201510– license €na to CAP Go technology for laminins for ex vivo cell culture therapies 2015-10-28
Cevec–iBET (PT): rec protein production, 201510 collab existent GenIbet is joint venture partner of Cevec 2015-10-28
Grifols–EU (govt): credit, 201510–202510 loan €100m from European Investment Bank 2015-10-28
Oryzon Genomics–PERSON: investment, 201510 private placement totalling $19m incl new investor Joseph Fernandez acquiring 1% shareholding 2015-10-27
Oryzon Genomics–SEVERAL: investment, 201510 private placement €16.61m w 4.9m news shares at €3.39/share led by Bank Solventis AV 2015-10-27
Novartis–Palobiofarma: cancer drug, 201510– license developm + commercialisation of adenosine receptor agonist PBF-509 2015-10-21
1 2 3  next pagenext page



Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download

» top

Advertisements

Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 40 Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture Berlin Partner HealthCapital BIO-Europe 2017 Germany November 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px 3 Picture EBD Group BioPharm America 2017 BPA Boston MA Save USD100 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px